Zurueck zur Suche

Reporte zur Charge E5MN5

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MN 2 MO 2 WI 2 IA 1 IL 1 MT 1 MD 1

VAERS 2711471

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge E5MN5

moderat
Staat
IA
Alter
36,0
Geschlecht
F
Eingang
08.11.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Arthralgia Injected limb mobility decreased

Symptomtext

right shoulder pain and having lots of difficulty moving arm and even pushing door open that continues even until 11.8.23

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2691405

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge E5MN5

moderat
Staat
MN
Alter
55,0
Geschlecht
F
Eingang
05.10.2023
Impfdatum
05.10.2023
Beginn
05.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest discomfort Chest pain Cold sweat Dyspnoea Swollen tongue Throat clearing

Symptomtext

The pt came into the flu vaccine clinic today at 1435 to receive her annual influenza vaccine. The writer administered the pt's vaccine in her right deltoid. The pt stated she felt good and thanked the writer for her vaccine and started to walk back to her office. Five to six minutes later the pt returned with a coworker stating that she had chest pain, SOB and a swollen tongue feeling in the back of her throat. The writer took the pt's BP, O2, Temp, pulse and respirations. The pt's blood pressure at 2:47PM was 151/108, her pulse was 78, respirations were 20, temperature was 98.7 and O2 was 98%. The pt was still clearing her throat and appeared cool and clammy. The pt respirations were labored but WNL at 20 respirations per min. The pt stated that her chest was tighter then before. The writer was trying to find the PO Benadryl, but none was available. Therefore, the writer had to administer 50mg/ml of Diphenhydramine via IM injection in the pt's left deltoid. The pt tolerated the injection well. The writer waited 10 mins later to take another set of vitals. The pt's BP was 161/113, respirations were 20, pulse was 72 and O2 level was 98%. The pt stated she was starting to feel woozy from the Benadryl but that her SOB felt better. The writer also gave the pt two apple juice boxes and a small bottle of water. The pt drank all of these liquids. The writer took the pt's vitals again 15 mins later at 1514. The pt's BP was 128/88, respirations were 18, pulse was 68 and O2 level was 99%. The pt stated that her SOB and chest pain was a lot better. The pt stated that she felt tired from the Benadryl but overall felt better. The writer suggested that the pt go to the emergency room to be seen in case anything else were to occur. The pt stated that she would just like to go home and rest and stated she will go in if anything changes. The writer told her to call if anything else changes or if she has any further questions. The pt agrees with this plan and communicated with her manager that she would be leaving for the day. The pt will not be taking the influenza vaccine next year through clinic. If the pt would like her vaccine she will need to go to her PCP or an allergist.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2699125

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge E5MN5

mild
Staat
MO
Alter
32,0
Geschlecht
F
Eingang
20.10.2023
Impfdatum
20.10.2023
Beginn
20.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Administration site pruritus Dizziness Lip pruritus Pruritus Urticaria

Symptomtext

10/20/2023-Flu vaccine and COVID booster admin at approx 1000. Employee returned to the Occ Health office at 1015 with c/o itching at flu admin site and right arm. Hives noted to R arm and chest. Employee denied SOB. Benadryl 25mg po given per S.O. Employee remained in Occ Health for observation. BP 122/84, pulse 76. EE c/o itching to lips, denies SOB. Additional dose of Benadryl 25mg po given. Employee drinking water. Rechecked BP at 1030. BP 127/85, Pulse 75, lungs clear. Employee reports feeling slightly dizzy. Employee declines to go to ER. S/s resolved at 1050. Employee left work with family to go home and rest.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Administration site pruritus
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknwon
Vorgeschichte
anxiety/depression
Andere Medikamente
Unknown
Allergien
Sulfa, PCN
Vorherige Impfungen
Flu-red knot at site

VAERS 2699087

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge E5MN5

mild
Staat
WI
Alter
27,0
Geschlecht
F
Eingang
20.10.2023
Impfdatum
18.10.2023
Beginn
19.10.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site erythema Injection site pruritus

Symptomtext

Pt stated had flu vaccine on 10/18/23 at 0500 to right arm. Pt stated site was ok on 10/18/23. Pt stated when woke up on 10/19/23 at 0630 she noticed a little redness and bruising at injection site. On 10/20/23 she noticed increase in redness at injection site and site was itchy. Pt concerned and will go to Occ. Health to be seen.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2690056

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge E5MN5

mild
Staat
IL
Alter
66,0
Geschlecht
F
Eingang
03.10.2023
Impfdatum
29.09.2023
Beginn
29.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Pt had flu vaccine on 9/29/23 at Left Deltoid. Pt developed reactions a few hours after vaccination. Initially swelling, redness, itching, and warm to touch on the left deltoid. Denies discharges. No fever. Pt still continues to experience itchiness and swelling at the injection site. Pt aware and watch for any signs of infection and worsening of symptoms. Pt is aware to follow up with her physician of choice for any worsening of symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2726503

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge E5MN5

gering
Staat
MT
Alter
60,0
Geschlecht
M
Eingang
21.12.2023
Impfdatum
21.12.2023
Beginn
21.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Device leakage Underdose

Symptomtext

When giving vaccine, plunger was pulled to aspirate, then plunger was pushed in to administer the vaccine. The contents of the syringe squirted out the sides between the needle hub and luer lock of the syringe. Possible manufacturer error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Device leakage
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2723793

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge E5MN5

gering
Staat
MO
Alter
59,0
Geschlecht
M
Eingang
13.12.2023
Impfdatum
04.12.2023
Beginn
04.12.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

medical assistant called to inform that earlier that day, a patient who had already received a dose of FluLaval in September received another dose of FluLaval; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 59-year-old male patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2023-2024 season) (batch number E5MN5) for prophylaxis. Concomitant products included Influenza vaccine inact split 4v (Flulaval quadrivalent). On 04-DEC-2023, the patient received the 2nd dose of FluLaval Quadrivalent 2023-2024 season. On 04-DEC-2023, an unknown time after receiving FluLaval Quadrivalent 2023-2024 season, the patient experienced extra dose administered (Verbatim: medical assistant called to inform that earlier that day, a patient who had already received a dose of FluLaval in September received another dose of FluLaval). The outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-DEC-2023 The reporter was a medical assistant called to inform that earlier that day, a patient who had already received a dose of FluLaval in September received another dose of FluLaval, which led to extra dose administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
FLULAVAL QUADRIVALENT
Allergien
-
Vorherige Impfungen
-

VAERS 2721765

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge E5MN5

gering
Staat
MN
Alter
0,5
Geschlecht
M
Eingang
07.12.2023
Impfdatum
01.12.2023
Beginn
01.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

No apparent reaction, no action needed to be taken

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None known
Vorgeschichte
Carrier of Hemoglobinopathy disorder
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2711977

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge E5MN5

gering
Staat
WI
Alter
11,0
Geschlecht
F
Eingang
09.11.2023
Impfdatum
08.11.2023
Beginn
08.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect dose administered No adverse event

Symptomtext

Patient received 0.5mL dose of Moderna COVID 6m-11y formulation due to overfill of single-dose vial. Patient was discharged in stable condition with no adverse symptoms reported at time of vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2703408

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge E5MN5

gering
Staat
MD
Alter
-
Geschlecht
U
Eingang
27.10.2023
Impfdatum
14.10.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

FluLaval was in a cooler with the temp log reading minus 1.6 Celsius; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent) (batch number E5MN5, expiry date 30-JUN-2024) for prophylaxis. On 14-OCT-2023, the patient received FluLaval Quadrivalent. On an unknown date, an unknown time after receiving FluLaval Quadrivalent, the patient experienced incorrect storage of drug (Verbatim: FluLaval was in a cooler with the temp log reading minus 1.6 Celsius). The outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-OCT-2023 The pharmacist reported that he had some FluLaval that was in a cooler with the temp log reading minus 1.6 Celsius. The vaccine was injected and the reporter wonder if need to revaccinate those individuals. 64 patients received the vaccine from the cooler reading minus 1.6 Celsius which led to incorrect storage of drug. The pharmacists reported that he had 185 doses, that had not been injected. The reporter consented to follow up via postal. The vaccine administration facility is the same as primary reporter. The Healthcare professional stated she would rather provide patient demographics at follow up. This case is linked with US2023AMR148062, same reporter.; Sender's Comments: US-GSK-US2023AMR148062:Original Case : US2023144281

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-